Loss of IL-6 receptor expression in cervical carcinoma cells inhibits autocrine IL-6 stimulation: Abrogation of constitutive monocyte chemoattractant protein-1 production

Journal of Immunology

Volumn 165, Issue 4, 2000, Pages 1939-1948

  Hess, S ^a   Smola, H ^a   De Silva, U S ^a   Hadaschik, D ^a   Kube, D ^a   Baldus, S E ^a   Flucke, U ^a   Pfister, H ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6 RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1;

ARTICLE; AUTOCRINE EFFECT; CANCER IMMUNOLOGY; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; MONOCYTE; PRIORITY JOURNAL; TARGET CELL; UTERINE CERVIX CARCINOMA; VIRUS CARCINOGENESIS;

EID: 0034663922     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.4.1939     Document Type: Article

References (70)

1. BCL-2 immunoreactivity increases with severity of CIN: A study of normal cervical epithelia, CIN, and cervical carcinoma
2. CD40 ligand-CD40 interaction induces chemokines in cervical carcinoma cells in synergism with IFN-γ
3. Expression of epidermal growth factor receptor and human papillomavirus E6/E7 proteins in cervical carcinoma cells
4. The autonomous growth of human papillomavirus type 16-immortalized keratinocytes is related to the endothelin-1 autocrine loop
5. Overexpression of the insulin-like growth factor-1 receptor and autocrine stimulation in human cervical cancer cells
6. Constitutive release of IL6 by human papillomavirus type 16 (HPV16)- harboring keratinocytes: A mechanism augmenting the NK-cell-mediated lysis of HPV-bearing neoplastic cells
7. Interleukin-6 (IL-6) functions as an autocrine growth factor in cervical carcinomas in vitro
8. Interleukin-6 in biology and medicine
9. Gp130 and the interleukin-6 family of cytokines
10. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway
11. Expression of monocyte chemoattractant protein 1 in human osteoblastic cells stimulated by proinflammatory mediators
12. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment
13. Interleukin-6 induces monocyte chemotactic protein-1 in peripheral blood mononuclear cells and in the U937 cell line
14. Identification of the human 26-kD protein, interferon β2 (IFN-β2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor
15. Induction of β2-interferon by tumor necrosis factor: A homeostatic mechanism in the control of cell proliferation
16. IFN-γ regulates the expression of the adhesion molecule ELAM-1 and IL-6 production by human endothelial cells in vitro
17. Interleukin 4 induces interleukin 6 production by endothelial cells: Synergy with interferon-γ
18. Cross-linking CD40 on B cells rapidly activates nuclear factor-κB
19. CD40 function in non-hematopoietic cells: Mobilization of NF-κB and induction of IL-6 production
20. Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-κB pathway involving TNF receptor-associated factors
21. Simultaneous production of interleukin 6, interferon-β and colony- stimulating activity by fibroblasts after viral and bacterial infection
22. Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas
23. Interleukin-6 (IL-6) functions as an in vitro autocrine growth factor in renal cell carcinomas
24. Interleukin-6 functions as an autocrine growth factor in human bladder carcinoma cell lines in vitro
25. Growth inhibition of human breast carcinoma and leukemia/lymphoma cell lines by recombinant interferon-β2
26. Contribution of IL-6 to the antiproliferative effect of IL-1 and tumor necrosis factor on tumor cell lines
27. Interleukin-6 in human multiple myeloma
28. Identification of interleukin-6 as an autocrine growth factor for Epstein-Barr virus-immortalized B cells
29. Involvement of IL-6 in mesangial proliferative glomerulonephritis
30. Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes
31. Interleukin-6 and interleukin-6 soluble receptor regulate proliferation of normal, human papillomavirus-immortalized, and carcinoma- derived cervical cells in vitro
32. IL-6 and APPs: Anti-inflammatory and immunosuppressive mediators
33. IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice
34. Correlations and interactions in the production of interleukin-6 (IL- 6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF
35. Role of oxygen radicals and IL-6 in IL-1-dependent cartilage matrix degradation
36. Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130
37. IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase
38. Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6
39. The function of the soluble interleukin 6 (IL-6) receptor in vivo: Sensitization of human soluble IL-6 receptor transgenic mice towards IL-6 and prolongation of the plasma half-life of IL-6
40. Stat3: A STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6
41. Molecular cloning and expression of an IL-6 signal transducer, gp130
42. Association of transcription factor APRF and protein kinase Jak1 with the interleukin-6 signal transducer gp130
43. Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 β receptor components
44. The designer cytokine hyper-interleukin-6 is a potent activator of STAT3-dependent gene transcription in vivo and in vitro
45. Identification of the interleukin-6/oncostatin M response element in the rat tissue inhibitor of metalloproteinases-1 (TIMP-1) promoter
46. Molecular and cytogenetic analysis of immortalized human primary keratinocytes obtained after transfection with human papillomavirus type 16 DNA
47. ImmunoMax: A maximized immunohistochemical method for the retrieval and enhancement of hidden antigens
48. Dye uptake methods for assessing viral cytopathogenicity and their application to interferon assays
49. A cytotoxic CD40/p55 tumor necrosis factor receptor hybrid detects CD40 ligand on Herpesvirus saimiri transformed T cells
50. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells
51. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells
52. Differential regulation of the JE gene encoding the monocyte chemoattractant protein (MCP-1) in cervical carcinoma cells and derived hybrids
53. The effect of the JE (MCP-1) gene, which encodes monocyte chemoattractant protein-1, on the growth of HeLa cells and derived somatic- cell hybrids in nude mice
54. Analysis of interleukin 6 gene expression in cervical neoplasia using a quantitative polymerase chain reaction assay: Evidence for enhanced interleukin 6 gene expression in invasive carcinoma
55. Activation of interleukin-6 gene expression through the NF-κB transcription factor
56. A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family
57. Transcription factors NF-IL6 and NF-κB synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8
58. Photodynamic therapy induces expression of interleukin 6 by activation of AP-1 but not NF-κB DNA binding
59. Modulation of the human interleukin-6 promoter (IL-6) and transcription factor C/EBPβ (NF-IL6) activity by p53 species
60. Repression of the interleukin 6 gene promoter by p53 and the retinoblastoma susceptibility gene product
61. The human papillomavirus type 16 E7 gene product interacts with and trans-activates the AP1 family of transcription factors
62. Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product
63. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
64. Membrane-bound and soluble interleukin-6 receptor: Studies on structure, regulation of expression, and signal transduction
65. Response to IL-6 of HPV-18 cervical carcinoma cell lines
66. Complex of soluble human IL-6-receptor/IL-6 up-regulates expression of acute-phase proteins
67. Major role of the soluble interleukin-6/interleukin-6 receptor complex for the proliferation of interleukin-6-dependent human myeloma cell lines
68. Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: Involvement of STAT3 in anti-apoptosis
69. Stat3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis: Generation and characterization of T cell-specific Stat3-deficient mice
70. Interleukin-6 (IL-6) as an anti-inflammatory cytokine: Induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55